Document is current
Any future updates will be listed below
-
Authors
Riaz, Nazia
Huibers, Anne
Leong, Stanley P.
Kashani-Sabet, Mohammed
White, Richard L. Jr.
Vetto, John T.
Schneebaum, Schlomo
O’Donoghue, Cristina
Howard, Harrison
Avisar, Eli
Namm, Jukes P.
Kosiorek, Heidi
Pockaj, Barbara
Faries, Mark
Karakousis, Giorgos
Zager, Jonathan S.
Olofsson Bagge, Roger
-
Funding
Funding for this research was provided by:
Sahlgresnka University Hospital (ALFGBG-965024, NHV-977897)
Svenska Sällskapet för Medicinsk Forskning
Swedish Research Council (2020-02446)
Kunt and Alice Wallenburg Foundation
Göteborgs Läkaresällskap
Cancerfonden (22 2355 Pj)
University of Gothenburg
- License Information
-
More Information
Article History
Received: 22 November 2024
Accepted: 10 January 2025
First Online: 1 February 2025
Disclosures
: Roger Olofsson Bagge has received institutional research grants from Bristol-Myers Squibb (BMS), Endomagnetics Ltd (Endomag), SkyLineDx and NeraCare GmbH; speaker honorarium from Roche, Pfizer, and Pierre-Fabre; has served on advisory boards for Amgen, BD/BARD, BMS, Merck Sharp & Dohme (MSD), Novartis, Roche, and Sanofi Genzyme; and is a shareholder in SATMEG Ventures AB. Nazia Riaz, Anne Huibers, Stanley P. Leong, Mohammed Kashani-Sabet, Richard L. White Jr, John T. Vetto, Schlomo Schneebaum, Cristina O´Donoghue, Harrison Howard, Eli Avisar, Jukes P. Namm, Heidi Kosiorek, Barbara Pockaj, Mark Faries, Giorgos Karakousis, and Jonathan S. Zager declare they have no conflicts of interest to disclose that may be related to the contents of this manuscript.
